Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05181540
Title A Phase 3 Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation (E-CELERATE)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Angiocrine Bioscience
Indications

Hodgkin's lymphoma

non-Hodgkin lymphoma

Therapies

AB-205

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.